AWH Aspira Womens Health Inc.

Aspira engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

$7.01  +0.30 (4.39%)
As of 03/08/2021 11:45:24 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Diagnostics & Research
USA
USA
07/12/2006
104,661,251
708,875
$702,800,300
0.00%
SEC Edgar Online
10-Q
10-K
04537Y109
US04537Y1091
BMVJKX2

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-46.20
48.30
155.73
-104.54%
-337.05%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy